BIT 0.00% 1.9¢ biotron limited

Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-388

  1. 901 Posts.
    lightbulb Created with Sketch. 52
    Yep. This has been my main complaint for over 3 years now. Love the company's assets, projects, and portfolio of compounds. The potential is undeniable. But this company has been stuck between 5 - 15c over the last 2.5 years - through a global pandemic - due to a management team that is happy to drag its heels. There is no sense of commercial urgency, very poor communication, and a lack of forward momentum.

    A very wise investor once told me: "if you are faced with a choice between investing in a company with a brilliant, commercially savvy and active management team but whose projects and assets are average, or a company with a brilliant portfolio of assets but run by management who are content to take their time and wait for deals to come to them, always choose the former".
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.